SCHEMBL10076240

SCHEMBL10076240

CCc1ccc(C(=O)N2CCN(C(C)=O)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A7 Q99884 1/20 0.58
DRD3 P35462 3/20 0.54
DRD2 P14416 1/20 0.54
KMT2A Q03164 4/20 0.52
ALDH1A1 P00352 4/20 0.52
GAA P10253 2/20 0.52
HTT P42858 2/20 0.52
HSP90AA1 P07900 2/20 0.52
HSP90AB1 P08238 2/20 0.52
HSD17B10 Q99714 2/20 0.52
MEN1 O00255 2/20 0.52
KDM4E B2RXH2 1/20 0.52
MAPT P10636 1/20 0.52
ALOX15 P16050 1/20 0.52
TSHR P16473 1/20 0.52
ALOX12 P18054 1/20 0.52
MAPK1 P28482 1/20 0.52
GFER P55789 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11955563 0.86 HRH3 (0.66) SLC6A7DRD3DRD2KMT2AMEN1
SCHEMBL300831 0.86 HPGD (0.68) SLC6A7KMT2AALDH1A1HTTHSD17B10
SCHEMBL10264405 0.86 ALDH1A1 (0.62) SLC6A7DRD3DRD2KMT2AALDH1A1
SCHEMBL7901274 0.84 HPGD (0.71) SLC6A7KMT2AALDH1A1HTTMEN1
SCHEMBL21321950 0.84 HPGD (0.71) SLC6A7KMT2AALDH1A1HTTMEN1
SCHEMBL19670957 0.82 HSP90AA1 (0.54) SLC6A7KMT2AALDH1A1HTTHSP90AA1
SCHEMBL17572991 0.82 LMNA (0.69) SLC6A7DRD3DRD2KMT2AALDH1A1
SCHEMBL10260239 0.81 SIGMAR1 (0.62) SLC6A7DRD3DRD2KMT2AALDH1A1
SCHEMBL8430053 0.81 HPGD (0.68) SLC6A7DRD3DRD2KMT2AALDH1A1
SCHEMBL309271 0.81 HPGD (0.64) KMT2AALDH1A1GAAHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200039989-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2020-02-06 US disclosed
US-8093231-B2 Sulfonylethyl phosphorodiamidates TELIK, INC. (US) 2012-01-10 US disclosed
US-20080039429-A1 SULFONYLETHYL PHOSPHORODIAMIDATES TELIK, INC. 2008-02-14 US disclosed
US-7262182-B2 Sulfonylethyl phosphorodiamidates TELIK, INC. (US) 2007-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200039989-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF CLK2, CLK1, CLK3 SLC6A7 3047/4885DRD3 1638/4885DRD2 1626/4885
US-20080039429-A1 SULFONYLETHYL PHOSPHORODIAMIDATES MTAP, TYMP, PHOSPHO1 SLC6A7 1090/4885DRD3 4317/4885DRD2 4302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.